The Jerusalem PostPentagon ignored warnings before Iranian drone strike killed six US soldiers, whistleblower allegesInquirer EntertainmentBianca Gonzalez shares how PBB prepares evictees for outside lifeInquirerAnnual 3-month sardine fishing ban starts in Zamboanga PeninsulaDaily MaverickANC cannot renew itself by looking inwards while voters turn awayZDF heuteEntdecken Sie das ZDF-NachrichtenstudioVilaWebLa CUP aposta pel conflicte amb l’estat espanyol com a via d’avenç socialRTL BoulevardACM: Investeerder HAL mag bouwbedrijf VolkerWessels overnemenSRF NewsGlobale Panne – Alter Programmfehler löste Microsoft-Ausfall ausEgypt IndependentTV host Amr Adib comments on Egyptian state selling lands to pay off debtABC NewsWATCH: New video of tanker collision and riverboat sinkingTechCrunchGoogle Maps can now build trip itineraries with real-time details about each stopVanguardASUP declares indefinite strike at Rivers polytechnic
The Daily Newsstand · Free, Always
Monday, November 16, 2026

Neumora Therapeutics GAAP EPS of -$0.18 beats by $0.02

Translate
  • Neumora Therapeutics press release (NMRA): Q3 GAAP EPS of -$0.18 beats by $0.02.
  • As of September 30, 2026, Neumora had cash and cash equivalents of $85.7 million.
  • Financial Guidance: Neumora is not providing updated financial runway guidance. As disclosed in our Quarterly
View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.